Search Results - "Reuveni, D."

The dual CCR2/CCR5 inhibitor Cenicriviroc ameliorates murine primary biliary cholangitis by Reuveni, D, Leung, P, Vig, P, Shibolet, O, Gershwin, E.M, Zigmond, E

Get full text

Moxifloxacin enhances antiproliferative and apoptotic effects of etoposide but inhibits its proinflammatory effects in THP-1 and Jurkat cells by Fabian, I, Reuveni, D, Levitov, A, Halperin, D, Priel, E, Shalit, I

“…Etoposide (VP-16) is a topoisomerase II (topo II) inhibitor chemotherapeutic agent. Studies indicate that VP-16 enhances proinflammatory cytokines secretion…”
Get full text

FRI-197 - Batf3-dependent CD103 + CD11b-dendritic cells are crucial for the development of primary biliary cholangitis by Reuveni, D., Assi, S., Leung, P., Shibolet, O., Gershwin, E., Zigmond, E.

Get full text

Batf3-dependent CD103 + CD11b-dendritic cells are crucial for the development of primary biliary cholangitis by Reuveni, D., Assi, S., Leung, P., Shibolet, O., Gershwin, E., Zigmond, E.

Get full text

PS-137 - The dual CCR2/CCR5 inhibitor Cenicriviroc ameliorates murine primary biliary cholangitis by Reuveni, D., Leung, P., Vig, P., Shibolet, O., Gershwin, E.M., Zigmond, E.

Get full text

Moxifloxacin enhances antiproliferative and apoptotic effects of etoposide but inhibits its proinflammatory effects in THP-I and Jurkat cells by FABIAN, I, REUVENI, D, LEVITOV, A, HALPERIN, D, PRIEL, E, SHALIT, I

Get full text